Contact Us
CMI Logo

Researchers and key players are focusing on the development of novel embolization products for the treatment of chronic diseases such as tumor, hemorrhage and others, which is expected to drive growth of the global embolization market over the forecast period.

For instance, in January 2021, MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, received the U.S. Food and Drug Administration approval for its PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, is designed with the latest MicroBraid technology, which features a lower profile delivery system compatible with the VIA 17 microcatheter, and includes additional device configurations.

Moreover, in November 2020, Fluidx Medical Technology, a U.S.-based embolic devices manufacturing company, introduced its novel GPX Embolic Device. It is an innovative embolic designed to combine the benefits of other embolics such as coils, particles, and liquids with simplified preparation, delivery, precision, and control leading to durable, long-term occlusions.

The global embolization market is estimated to be valued at US$ 1,433.6 million in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027).

Figure 1. Global Embolization Market Share (%) in Terms of Value, By Region, 2020

Embolization  | Coherent Market Insights

Increasing incidence of chronic diseases is expected to drive the market growth over the forecast period.

The increasing incidence of chronic diseases such as cancer, cardiovascular diseases, neurovascular diseases, and others is expected to drive growth of the global embolization market over the forecast period.

For instance, according to the World Health Organization statistics published in March 2021, cancer is the second leading cause of deaths globally, and is responsible for about 10 million deaths per year, across the globe, and about one in six deaths is due to cancer. Furthermore, according to the same source, an estimated 9.6 million deaths occurred due to cancer in 2018, globally.

Additionally, according to the Global Burden of Disease (GBD), an article published in the National Center for Biotechnology Information (NCBI) in July 2020, prevalence of ischemic heart disease is increasing. The GBD datasets analyzed that in 2020, the prevalence rate of ischemic heart disease was 1,655 per 100,000 global population, and is expected to exceed 1,845 by 2030.

Moreover, according to the Brain Aneurysm Foundation report 2020, there are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half of the victims are younger than 50 years of age.

request-sample

Embolization Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 1,433.6 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 8.1% 2027 Value Projection: US$ 2,468.7 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Particles (Radioembolization Spheres, Drug-Eluting Beads, Microspheres (or Blands beads, without drug), PVA particles (Polyvinyl Alcohol)), Liquid Embolic, Plugs, Coils
  • By Indication: Hemorrage/Bleeding, Benign Prostatic Hyperplasia (BPH), Uterine Fibroid, Tumor (Malignant, including Liver Cancer), Malformation (AVM, AVF), Venous embolization (incl. Varicocele for ex), Others
  • By End User: Hospitals & Clinics, Ambulatory Surgical Centers, Others
Companies covered:

IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson

Growth Drivers:
  • Increasing novel product launches and approvals
  • Increasing incidence of chronic diseases
Restraints & Challenges:
  • Product recalls
  • Complications associated with embolization

Figure 2. Global Embolization Market Share (%), by Product Type, 2020

Embolization  | Coherent Market Insights

Global Embolization Market– Impact of Coronavirus (Covid-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus (COVID-19) has resulted in over 122 million infected individuals worldwide, as of March 19, 2021.

The coronavirus or COVID-19 outbreak that started from Wuhan, China has spread across continents, affecting various industries globally. Supply of key materials such as probes required for interventional ablation have been severely disrupted due to forced quarantine, and imposed lockdowns in various countries. This has led to disruption in the link between regional warehouses, the transportation of materials between regions cannot be carried out successfully. This shortage of medical devices such as embolic coils, plugs required for embolization procedures have affected the supply chain of the global embolization market.

Moreover, the hospitals are delaying the uterine fibroid embolization of patients who are stable and the surgery can be postponed, or suggesting patients to undergo the treatment from outpatient’s services, to reduce the high risk of getting infected by the COVID-19.

Global Embolization Market Restraint

Product recall is a voluntary action taken, when laws administered by the U.S. Food and Drug Administration (FDA) are violated by manufacturers and distributors. The action is taken to protect public from the risk of injuries. Increasing number of product recalls of embolization products by various developers/manufacturers is expected to hinder growth of the market.

For instance, in March 2020, Medtronic Plc recalled Pipeline Flex Embolization Device (available in the U.S.) and Pipeline Flex Embolization Device with Shield Technology. The reason behind the recall of these two products is that there is a risk of the delivery system, which will fracture while placing the stent inside the patient. The U.S. FDA received 50 Medical Device Reports, with 10 injuries and one death regarding these embolization products from November 1, 2019 to March 1, 2020.

Key Players

Major players operating in the global embolization market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson

Infoimg

Embolization is a minimally invasive treatment procedure that blocks one or more blood vessels or abnormal vascular channels. Embolization procedure requires various types of embolization particles such as radioembolization spheres, drug-eluting beads, microspheres, PVA particles (Polyvinyl Alcohol), and other products such as liquid embolic, plugs, and coils. Embolization procedure is used in the treatment of various chronic diseases such as cancer, uterine fibroid, and other complications of chronic diseases.

Market Dynamics

The academic and research institutes are focusing on the research and development in embolization PVA particles (polyvinyl alcohol), which is expected to drive the market growth over the forecast period

For instance, in April 2019, Washington University School of Medicine, a research university in the U.S., initiated the clinical trial study on Middle Meningeal Artery Embolization with polyvinyl alcohol particles (PVA) on August 2019 and the clinical trial study is expected to be completed by January 1, 2022

Key features of the study:

  • This report provides in-depth analysis of the global embolization market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global embolization market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global embolization market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global embolization market

Detailed Segmentation:

  • Global Embolization Market, By Product Type:
    • Particles
      • Radioembolization Spheres
      • Drug-eluting Beads
      • Microspheres (or Blands beads, without drug)
      • PVA particles (Polyvinyl Alcohol)
    • Liquid Embolic
    • Plugs
    • Coils
  • Global Embolization Market, By Indication:
    • Hemorrage/Bleeding
    • Benign Prostatic Hyperplasia (BPH)
    • Uterine Fibroid
    • Tumor (Malignant, including Liver Cancer)
    • Malformation (AVM, AVF)
    • Venous embolization (incl. Varicocele for ex)
    • Others
  • Global Embolization Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
    • Others
  • Global Embolization Market, By Region:
    • North America
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Particles
          • Radioembolization Spheres
          • Drug-eluting Beads
          • Microspheres (or Blands beads, without drug)
          • PVA particles (Polyvinyl Alcohol)
        • Liquid Embolic
        • Plugs
        • Coils
      • By Indication
        • Hemorrage/Bleeding
        • Benign Prostatic Hyperplasia (BPH)
        • Uterine Fibroid
        • Tumor (Malignant, including Liver Cancer)
        • Malformation (AVM, AVF)
        • Venous embolization (incl. Varicocele for ex)
        • Others
      • By End User
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
        • Others
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • IMBiotechnologies Ltd. *
      • Company Overview
      • Product Portfolio
      • Financial Overview
      • Key Highlights
      • Market Strategies
    • ABK Biomedical Inc.
    • EmboMedics
    • Guerbet
    • Boston Scientific Corporation
    • Medtronic Plc.
    • Varian Medical Systems, Inc.
    • Terumo Corporation
    • Merit Medical Systems, Inc.
    • Cook Group
    • Johnson & Johnson

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Indication
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario
    • Acquisition, Collaboration, and Agreement
    • Epidemiology
    • PEST Analysis
    • Reimbursement Scenario
    • Pricing Analysis, By Procedure
  4. Global Embolization Market – Impact of Coronavirus (Covid-19) Pandemic
    • Government Initiatives
    • Impact on Supply and Demand
    • Clinical Trial Impact Analysis
  5. Global Embolization Market, By Product Type, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Particles
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Radioembolization Spheres
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Drug-eluting Beads
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • Microspheres (or Blands beads, without drug)
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
        • PVA particles (Polyvinyl Alcohol)
          • Introduction
          • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
          • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Liquid Embolic
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Plugs
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Coils
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  6. Global Embolization Market, By Indication, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hemorrage/Bleeding
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Benign Prostatic Hyperplasia (BPH)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Uterine Fibroid
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Tumor (Malignant, incl Liver Cancer)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Malformation (AVM, AVF)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Venous embolization (incl. Varicocele for ex)
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  7. Global Embolization Market, By End User, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast by volume, and Y-o-Y Growth, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, and Y-o-Y Growth, 2020 – 2027, (US$ Mn)
  8. Global Embolization Market, By Region, 2020 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country, 2020 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Product Type, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Product Type, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Indication, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Indication, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By End User, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By End User, 2020 – 2027, (US$ Mn)
      • Market Size and Forecast Volume, and Y-o-Y Growth, By Country, 2016–2027, (No. of Procedures)
      • Market Size and Forecast, By Country/Region, 2020 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  9. Competitive Landscape
    • Market Share Analysis
      • IMBiotechnologies Ltd. *
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • ABK Biomedical Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • EmboMedics
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Guerbet
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Varian Medical Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Terumo Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merit Medical Systems, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Cook Group
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 206 market data tables and 56 figures on "Embolization Market” - Global forecast to 2027

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Data Triangulation Methodology | Coherent Market Insights

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Market Analysis | Coherent Market Insights

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Subscribe Newsletter

Kindly subscribe for our latest news & articles.